Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches
Cc-BY
Lưu vào:
Tác giả chính: | , , |
---|---|
Định dạng: | Sách |
Ngôn ngữ: | English |
Thông tin xuất bản: |
Springer
2023
|
Chủ đề: | |
Truy cập trực tuyến: | https://link.springer.com/article/10.1007/s11356-023-29935-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/9385 |
Từ khóa: |
Thêm từ khóa bạn đọc
Không có từ khóa, Hãy là người đầu tiên gắn từ khóa cho biểu ghi này!
|
id |
oai:localhost:PNK-9385 |
---|---|
record_format |
dspace |
spelling |
oai:localhost:PNK-93852023-10-02T02:24:59Z Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches Elblehi, Samar S. Hafez, Mona H. El-Far, Ali H. CYP Ginseng+CYP Cc-BY Cypermethrin (CYP) is a synthetic pyrethroid utilized as an insecticide in agriculture and various pest eradication programs. However, it induces numerous health hazards for animals and humans. Therefore, the current study used Panax ginseng root extract (ginseng) to reduce the hepatorenal damage caused by commercially used CYP. Thirty-two male Wistar albino rats were distributed into control, ginseng (300 mg/kg B.W/day), CYP (4.67 mg/kg B.W.), and Ginseng+CYP (rats received both CYP and ginseng). All treatments were administered orally for 30 consecutive days. Cypermethrin induced harmful effects on hepatic and renal tissues through a substantial decline in body weight in addition to a considerable increase in liver enzymes, functional renal markers, and cholesterol. Also, CYP significantly decreased acetylcholinesterase (AChE) activity and increased pro-inflammatory cytokines (interleukin-1β (IL-1β), IL-6, and tumor necrosis factor-α (TNF-α)). Moreover, a marked increase in malondialdehyde level with a significant drop in reduced glutathione level and total superoxide dismutase (T-SOD) and catalase (CAT) activities was reported in the CYP group in kidney and liver tissues. 2023-10-02T02:24:59Z 2023-10-02T02:24:59Z 2023 Book https://link.springer.com/article/10.1007/s11356-023-29935-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/9385 en application/pdf Springer |
institution |
Trường Đại học Phenikaa |
collection |
DSpace |
language |
English |
topic |
CYP Ginseng+CYP |
spellingShingle |
CYP Ginseng+CYP Elblehi, Samar S. Hafez, Mona H. El-Far, Ali H. Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
description |
Cc-BY |
format |
Book |
author |
Elblehi, Samar S. Hafez, Mona H. El-Far, Ali H. |
author_facet |
Elblehi, Samar S. Hafez, Mona H. El-Far, Ali H. |
author_sort |
Elblehi, Samar S. |
title |
Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
title_short |
Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
title_full |
Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
title_fullStr |
Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
title_full_unstemmed |
Panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
title_sort |
panax ginseng ameliorates hepatorenal oxidative alterations induced by commercially used cypermethrin in male rats: experimental and molecular docking approaches |
publisher |
Springer |
publishDate |
2023 |
url |
https://link.springer.com/article/10.1007/s11356-023-29935-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/9385 |
work_keys_str_mv |
AT elblehisamars panaxginsengameliorateshepatorenaloxidativealterationsinducedbycommerciallyusedcypermethrininmaleratsexperimentalandmoleculardockingapproaches AT hafezmonah panaxginsengameliorateshepatorenaloxidativealterationsinducedbycommerciallyusedcypermethrininmaleratsexperimentalandmoleculardockingapproaches AT elfaralih panaxginsengameliorateshepatorenaloxidativealterationsinducedbycommerciallyusedcypermethrininmaleratsexperimentalandmoleculardockingapproaches |
_version_ |
1787095355521761280 |